Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2601 ARTíCULOS , VIENDO DEL 76 AL 90

PUBMED

Autonomic disorders predicting Parkinson's disease.

Palma JA, Kaufmann H.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S94-8. doi: 10.1016/S1353-8020(13)70024-5. Review.

0

0

0

PUBMED

Interactions between cognitive and sensory load while planning and controlling complex gait adaptations in Parkinson's disease.

Pieruccini-Faria F, Ehgoetz Martens KA, Silveira CR, Jones JA, Almeida QJ.

BMC Neurol. 2014 Dec 21;14:250. doi: 10.1186/s12883-014-0250-8.

0

0

0

PUBMED

Loudness perception and speech intensity control in Parkinson's disease.

Clark JP, Adams SG, Dykstra AD, Moodie S, Jog M.

J Commun Disord. 2014 Sep-Oct;51:1-12. doi: 10.1016/j.jcomdis.2014.08.001.

0

0

0

PUBMED

Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease.

Casida JE, Ford B, Jinsmaa Y, Sullivan P, Cooney A, Goldstein DS.

Chem Res Toxicol. 2014 Aug 18;27(8):1359-61. doi: 10.1021/tx5002223.

0

0

0

PUBMED

Effects of levodopa on retina in Parkinson disease.

Sen A, Tugcu B, Coskun C, Ekinci C, Nacaroglu SA.

Eur J Ophthalmol. 2014 Jan-Feb;24(1):114-9. doi: 10.5301/ejo.5000338.

0

0

0

PUBMED

Resting-state fMRI sheds light on neural substrates of cognitive decline in Parkinson disease.

Shinotoh H, Tessitore A.

Neurology. 2014 Nov 25;83(22):2000-1. doi: 10.1212/WNL.0000000000001037. No abstract available.

0

0

0

PUBMED

A personalized coaching program increases outdoor activities and physical fitness in sedentary Parkinson patients; a post-hoc analysis of the ParkFit trial.

van der Kolk NM, van Nimwegen M, Speelman AD, Munneke M, Backx FJ, Donders R, Post B, Overeem S, Bloem BR.

Parkinsonism Relat Disord. 2014 Dec;20(12):1442-4. doi: 10.1016/j.parkreldis.2014.10.004. No abstract available.

0

0

0

PUBMED

RIT2, a susceptibility gene for Parkinson's disease in Iranian population.

Emamalizadeh B, Movafagh A, Akbari M, Kazeminasab S, Fazeli A, Motallebi M, Shahidi GA, Petramfar P, Mirfakhraie R, Darvish H.

Neurobiol Aging. 2014 Dec;35(12):e27-8. doi: 10.1016/j.neurobiolaging.2014.07.013. No abstract available.

0

0

0

PUBMED

Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease.

Marconi S, Zwingers T.

Eur Rev Med Pharmacol Sci. 2014 Jul;18(13):1879-82. Review.

0

0

0

PUBMED

[Neurological common diseases in the super-elder society. Topics: IV. Parkinson's disease; 1. The noticeable earrly symptoms of Parkinson's disease].

Yoritaka A.

Nihon Naika Gakkai Zasshi. 2014 Aug 10;103(8):1854-60. Japanese. No abstract available.

0

0

0

PUBMED

Neural correlates of progressive reduction of bradykinesia in de novo Parkinson's disease.

Lee E, Lee JE, Yoo K, Hong JY, Oh J, Sunwoo MK, Kim JS, Jeong Y, Lee PH, Sohn YH, Kang SY.

Parkinsonism Relat Disord. 2014 Dec;20(12):1376-81. doi: 10.1016/j.parkreldis.2014.09.027.

0

0

0

PUBMED

Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.

Al-Bachari S, Parkes LM, Vidyasagar R, Hanby MF, Tharaken V, Leroi I, Emsley HC.

Neuroimage Clin. 2014 Aug 1;6:1-8. doi: 10.1016/j.nicl.2014.07.014.

0

0

0

PUBMED

Association of Parkinson's disease with altered serum levels of lead and transition metals among South Indian subjects.

Kumudini N, Uma A, Devi YP, Naushad SM, Mridula R, Borgohain R, Kutala VK.

Indian J Biochem Biophys. 2014 Apr;51(2):121-6.

0

0

0

PUBMED

Reasons for Parkinson's disease admissions in a large inner city hospital.

Arasalingam A, Clarke CE.

Parkinsonism Relat Disord. 2014 Feb;20(2):237-8. doi: 10.1016/j.parkreldis.2013.10.011. No abstract available.

0

0

0

PUBMED

Mechanism of the beneficial effect of melatonin in experimental Parkinson's disease.

Yildirim FB, Ozsoy O, Tanriover G, Kaya Y, Ogut E, Gemici B, Dilmac S, Ozkan A, Agar A, Aslan M.

Neurochem Int. 2014 Dec;79:1-11. doi: 10.1016/j.neuint.2014.09.005.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy